Rohtak, November 18
India is going to be amongst the pioneering nations of the world with the development of its indigenous Covid vaccine Covaxin in the near future. Indian Covid-19 vaccine is unique as it has shown minimum side-effects.
This was stated by Dr OP Kalra, Vice Chancellor of Pt Bhagwat Dayal Sharma University of Health Sciences, Rohtak, while addressing a news conference here today.
Professor Kalra disclosed that the third phase of the clinical human trials of Covaxin would begin at the Rohtak PGIMS on November 19. — TNS